Cardiogen and CJC-1295 (without DAC) Interaction

Synergistic
Mechanism-based 47% confidence

Cardiogen and CJC-1295 (without DAC) have a synergistic interaction with 47% confidence. Cardiogen and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

Cardiogen

AEDR | Cardiovascular Bioregulator Peptide

Cardiogen works through epigenetic regulation by penetrating cell nuclei and interacting with specific DNA regions, histones, and nucleosomes. It regulates which genes are activated or suppressed without changing DNA sequence.

Half-life: Minutes (short peptide); effects persist via epigenetic changes Typical dose: 10-20 mg daily longevity, healing
teratogenic
View full profile

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Combined Organ Load

Blood Vessels
low
GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Cardiogen, CJC-1295 (without DAC)). Monitor accordingly.

Frequently Asked Questions

Can I take Cardiogen with CJC-1295 (without DAC)?

Yes, Cardiogen and CJC-1295 (without DAC) can generally be taken together. Cardiogen and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is Cardiogen and CJC-1295 (without DAC) safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Cardiogen and CJC-1295 (without DAC)?

Cardiogen and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Cardiogen and CJC-1295 (without DAC)?

Cardiogen has a half-life of Minutes (short peptide); effects persist via epigenetic changes and CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Cardiogen vs CJC-1295 (without DAC)

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.